Dr. Timothy F Cloughesy, MD
Claim this profileJonsson Comprehensive Cancer Center at UCLA
Studies Glioblastoma
Studies Benign Glioma
11 reported clinical trials
16 drugs studied
Area of expertise
1Glioblastoma
H3
WHO
brainstem
2Benign Glioma
H3
WHO
brainstem
Affiliated Hospitals
Clinical Trials Timothy F Cloughesy, MD is currently running
APL-101
for Lung Cancer
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Recruiting1 award Phase 211 criteria
Pembrolizumab + Vaccine
for Glioblastoma
This trial is testing a combination of an immunotherapy drug, pembrolizumab, and a vaccine, ATL-DC, in patients with recurrent glioblastoma that can be surgically removed. The goal is to see if this combination can help the immune system better attack the cancer and improve patient outcomes.
Recruiting0 awards Phase 126 criteria
More about Timothy F Cloughesy, MD
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Timothy F Cloughesy, MD has experience with
- ATL-DC Vaccine
- Pembrolizumab
- ONC201
- Terameprocol
- NT-I7
- BGB-290
Breakdown of trials Timothy F Cloughesy, MD has run
Glioblastoma
Benign Glioma
- Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas
- BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
- Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas
Brain Tumor
Relapse
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Timothy F Cloughesy, MD specialize in?
Timothy F Cloughesy, MD focuses on Glioblastoma and Benign Glioma. In particular, much of their work with Glioblastoma has involved H3 patients, or patients who are WHO.
Is Timothy F Cloughesy, MD currently recruiting for clinical trials?
Yes, Timothy F Cloughesy, MD is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Timothy F Cloughesy, MD has studied deeply?
Yes, Timothy F Cloughesy, MD has studied treatments such as ATL-DC Vaccine, Pembrolizumab, ONC201.
What is the best way to schedule an appointment with Timothy F Cloughesy, MD?
Apply for one of the trials that Timothy F Cloughesy, MD is conducting.
What is the office address of Timothy F Cloughesy, MD?
The office of Timothy F Cloughesy, MD is located at: Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California 90095 United States. This is the address for their practice at the Jonsson Comprehensive Cancer Center at UCLA.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.